Targeting Apelinergic System in Cardiometabolic Disease

E-ISSN： 1873-5592|18|15|1785-1791

ISSN： 1389-4501

Source： Current Drug Targets, Vol.18, Iss.15, 2017-10, pp. : 1785-1791

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The apelinergic system: a promising therapeutic target

By Falcão-Pires Inês Ladeiras-Lopes Ricardo Leite-Moreira Adelino F

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 633-645

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer's disease: Targeting the Cholinergic System

Current Neuropharmacology, Vol. 14, Iss. 1, 2016-01 ,pp. : 101-115

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Epigenetics in Nervous System Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 1, 2013-02 ,pp. : 126-141

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological, Immunological, and Gene Targeting of the Renin-Angiotensin System for Treatment of Cardiovascular Disease

Current Pharmaceutical Design, Vol. 13, Iss. 12, 2007-04 ,pp. : 1199-1214

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges

Current Drug Targets, Vol. 18, Iss. 15, 2017-10 ,pp. : 1754-1778

Bentham Science Publishers

Access to resources Recommend Favorite